Aclaris Therapeutics Inc. Stock Price (ACRS)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Precision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call TranscriptFri, 16 Nov 2018 23:25:07 UTC via Seeking Alpha
Akebia Therapeutics Is An Attractive Investment In 2018Fri, 16 Nov 2018 17:42:35 UTC via Seeking Alpha
How Tap an ex-US Healthcare BoomFri, 16 Nov 2018 11:40:46 UTC via ETF Trends
DiaMedica Therapeutics Aims For $15 Million IPOFri, 16 Nov 2018 10:23:50 UTC via Seeking Alpha
CareTrust: Wait For A Drop Before Buying This 4.2%-Yielding Healthcare REITThu, 15 Nov 2018 07:43:08 UTC via Seeking Alpha
Mallinckrodt Plc (MNK) Presents at Jefferies London Healthcare Broker Conference Call (Transcript)Wed, 14 Nov 2018 23:28:08 UTC via Seeking Alpha
Cytori Therapeutics Inc (CYTX) CEO Marc Hedrick on Q3 2018 Results - Earnings Call TranscriptWed, 14 Nov 2018 22:54:12 UTC via Seeking Alpha
Geron Corporation (GERN) CEO John Scarlett Presents at Stifel 2018 Healthcare Conference Call TranscriptWed, 14 Nov 2018 19:49:15 UTC via Seeking Alpha
Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q3 2018 Results - Earnings Call TranscriptWed, 14 Nov 2018 19:23:03 UTC via Seeking Alpha
Walgreens Boots Alliance's (WBA) CEO Stefano Pessina Credit Suisse Healthcare Conference - TranscriptWed, 14 Nov 2018 18:50:08 UTC via Seeking Alpha

Aclaris Therapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACRS

You don't have any alerts set for IEX:ACRS.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

CEONeal Walker IndustryBiotechnology SectorHealthcare Websitehttp://www.aclaristx.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time ACRS to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.